Aarti Pharmalabs Ltd

NSE: AARTIPHARM · BSE: 543748 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹939.55
Market cap: ₹8,520 Cr
Revenue (annual): ₹1,819 Cr
Net profit (annual): ₹174.7 Cr
P/E (TTM): 40.0×Sector 50.4×
Promoter holding: 42.86%-0.22% QoQ
FII holding: 8.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Promoter Selling 4 Management Change 1 Legal & Regulatory 1 Earnings Call 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements with these filters

25 Sep 2026 16:06 IST BSE

Promoter Selling

Aarti Pharmalabs Promoter Selling: ₹106.4 Cr

Promoters sold a total of 15.12 lakh shares via open market transactions, aggregating to ₹106.43 Crore.

Value: ₹106.4 Cr

Read the filing ↗

23 Sep 2026 11:17 IST BSE

Promoter Selling

Aarti Pharmalabs Promoter Selling

Aarti Pharmalabs promoters sold a net 29.03 lakh shares, reducing their stake from 42.88% to 39.66%. No transaction value is disclosed in this periodic SAST filing.

Read the filing ↗

9 Sep 2026 12:32 IST BSE

Promoter Selling

Aarti Pharmalabs Promoter Selling: ₹10.43 Cr

Promoter Group entities, Safechem Enterprises and Relacion Trusteeship, sold 1,19,400 shares of Aarti Pharmalabs in the open market for a total of ₹10.43 Crore.

Value: ₹10.43 Cr

Read the filing ↗

7 Sep 2026 16:34 IST BSE

Promoter Selling

Aarti Pharmalabs Promoter Selling: ₹2.59 Cr

Safechem Enterprises Private Limited, part of the promoter group, sold 30,000 equity shares of Aarti Pharmalabs Ltd in the open market.

Value: ₹2.59 Cr
Promoter stake change: -0.03%

Read the filing ↗